October

October 6, 2014

Molecular therapy for Human Leukemias: Campothecin (CPT) suppresses B-Cell and myeloid leukemias via up regulation of the tumor suppressor IRF4, 6/October/2014, 13.10

The 1975 Nobel laureate in Physiology/Medicine Prof. David Baltimore, from California Institute of Technology, California, USA, had reported in the July 8, 2014 Blood that: “Dual mechanisms by which MiR-125b represses IRF4 to induce myeloid […]
October 6, 2014

Insights into the treatment of Th2-mediated inflammation and allergic diseases: 17α-E2 (an estrogen derivative) alleviates Th2-medited inflammation and Allergy via up regulation of its target gene., 06/October/2014, 10.10 am

A study from the University of California, Los Angeles; California Institute of Technology, Pasadena; Medical Research Council; and National Institute for Medical Research, London has reported that “Transcriptomics identified a […]
October 6, 2014

MiRNA-based Anti-Cancer stem cell therapy: MiRNA-127 inhibits the expression of Nucleostemin and reprogramming of somatic cells via up regulation of its target genes, 6/October/2014, 7.59 am

The 1989 Nobel prize winner in Physiology/Medicine, Prof. Bishop JM, Qu J and others from G.W. Hooper Foundation, University of California at San Francisco, San Francisco, California 94143, USA has published a research paper in the 11 June […]
October 6, 2014

Yoga therapy for Alzheimer’s disease: Nisshesha rechaka pranayama (Brief Intermittent Hypoxia) protects against amyloid deposition and toxicity in Alzheimer’s disease via up regulation of its target gene, 6/October/2014, 7.09 am

A recent study from the Gladstone Institute of Neurological Disease, San Francisco, California, USA shows that “Progranulin protects against amyloid β deposition and toxicity in Alzheimer’s disease mouse models.“ This […]